|
The ornamental design for a pharmaceutical tablet, as shown and described.
|
The “APR” logo forming part of the claimed design is a registered trademark of Celgene Corporation.
The broken line showing of the number “10” in the figures is included for the purpose of illustrating environment and forms no part of the claimed design.
Patent | Priority | Assignee | Title |
D755949, | Jul 30 2013 | RB HEALTH US LLC | Tablet |
D779601, | Jan 25 2012 | Yoga block | |
D787042, | Apr 28 2015 | Celgene Corporation | Pharmaceutical tablet |
D787043, | Jun 23 2015 | Celgene Corporation | Pharmaceutical tablet |
D813372, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D821682, | Mar 16 2016 | Intercontinental Great Brands LLC | Confection |
D835258, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D858741, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D906513, | Mar 19 2019 | Novo Nordisk A S | Pill |
D907760, | Jan 20 2017 | SOCIÉTÉ DES PRODUITS NESTLÉ S A | Orally ingestible tablet |
D908309, | Mar 13 2017 | BARILLA G E R FRATELLI S P A | Food product |
D927124, | Mar 13 2017 | BARILLA G E R FRATELLI S P A | Food product |
D933934, | Mar 13 2017 | BARILLA G E R FRATELLI S P A | Food product |
D947358, | Mar 19 2019 | Novo Nordisk A/S | Pill |
D957087, | Jan 08 2021 | Wm. Wrigley Jr. Company; WM WRIGLEY JR COMPANY | Three-dimensional confectionery product |
Patent | Priority | Assignee | Title |
3281620, | |||
4503031, | Dec 17 1982 | Super-fast-starting-sustained release tablet | |
CA89374, | |||
D285364, | Dec 28 1984 | Smith Kline & French Laboratories Limited | Pharmaceutical tablet |
D304626, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
D334420, | May 14 1991 | Ecolab USA Inc | Chemical detergent block |
D334421, | May 14 1991 | Ecolab USA Inc | Chemical detergent block |
D377977, | Jan 19 1994 | Glaxo Group Limited | Depression for a tablet |
D413972, | Jul 06 1998 | Pfizer Inc | Pharmaceutical tablet |
D413973, | Jul 06 1998 | Pfizer Inc | Pharmaceutical tablet |
D432641, | Apr 07 1998 | Pfizer Inc | Pharmaceutical tablet |
D433750, | Apr 07 1998 | Pfizer Inc | Pharmaceutical tablet |
D434846, | Jul 07 1999 | Merck Sharp & Dohme Corp | Tablet |
D459798, | Mar 26 2001 | AVENTIS PHARMA S A | Pill tablet |
D506544, | Jan 13 2004 | JOHNSON & JOHNSON CONSUMER INC | Medicinal tablet |
D515202, | Jul 19 2004 | Merck Sharp & Dohme Corp | Tablet |
D534646, | Jan 06 2006 | Access Business Group International LLC | Nutritional supplement tablet |
D535016, | Apr 22 2005 | WM WRIGLEY JR COMPANY | Elongated tablet |
D549724, | Nov 10 2005 | Sony Corporation | Computer generated image for a display panel or screen |
D549725, | Nov 10 2005 | Sony Corporation | Computer generated image for a display panel or screen |
D564086, | May 30 2005 | Takeda Nycomed AS | Tablet |
D636865, | Aug 25 2010 | KVK-Tech, Inc. | Pharmaceutical tablet |
D667430, | Apr 22 2010 | GOOGLE LLC | Electronic device with a graphical display element |
D671636, | Apr 23 2010 | DAIICHI SANKYO COMPANY, LIMITED | Pharmaceutical tablet |
D685460, | Aug 27 2009 | AstraZeneca AB | Tablet |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jun 25 2012 | Celgene Corporation | (assignment on the face of the patent) | / | |||
Jul 31 2012 | BHAT, SRENIVAS S | Celegene Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 028693 | /0499 | |
Nov 21 2019 | Celgene Corporation | Amgen Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 051181 | /0038 |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |